The biological significance of soluble interleukin-2 receptors in solid tumors.
暂无分享,去创建一个
S. Barni | G. Maestroni | A. Conti | P. Lissoni | G. Tancini | F. Rovelli | S. Viviani
[1] S. Barni,et al. Increased Level of Soluble Interleukin-2 Receptor in Advanced Solid Tumors: A Preliminary Study , 1988, Tumori.
[2] W. Boswell,et al. Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected]. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] B. Edwards,et al. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Lestani,et al. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. , 1987, British Journal of Cancer.
[5] G. Jay,et al. The released interleukin 2 receptor binds interleukin 2 efficiently. , 1986, Journal of immunology.
[6] D. Nelson,et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. , 1985, Journal of immunology.
[7] J. Koziol,et al. Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations , 1984, Cancer.
[8] J. Yokota,et al. Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer. , 1983, Clinical and experimental immunology.